Related Experiment Video
Updated: Jun 22, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Stent implantation in chronic mesenteric ischemia
1Radiology Department, Ege University School of Medicine, Izmir, Turkey.
Acta Radiologica (Stockholm, Sweden : 1987)
|June 3, 2009
Summary
Stent placement effectively treats chronic mesenteric ischemia (CMI), a serious condition affecting mesenteric arteries. This endovascular approach offers high success rates and a low complication incidence for CMI patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Gastroenterology
Background:
- Chronic mesenteric ischemia (CMI) is a critical condition caused by celiac or mesenteric artery stenosis or occlusion.
- Symptoms include nausea, vomiting, postprandial pain, and weight loss.
Purpose of the Study:
- To evaluate the effectiveness and short-term outcomes of stent placement in patients with stenotic mesenteric arteries.
- To assess the role of endovascular treatment in managing CMI.
Main Methods:
- 15 patients with CMI underwent primary stent placement for stenotic mesenteric arteries.
- Follow-up included clinical assessment and Doppler ultrasound at 1, 6, and 12 months.
- Restenosis was managed with digital subtraction angiography and balloon angioplasty if needed.
Main Results:
- 100% technical success rate in treating 18 stenoses with primary stenting.
- 86.6% clinical success rate in 15 patients.
- 12-month primary patency rate of 81%; complication rate of 0.06%.
Conclusions:
- Stent placement is a viable option for managing chronic mesenteric ischemia.
- The procedure demonstrates high technical and clinical success rates with a low complication incidence.
- Endovascular treatment offers a promising therapeutic role for CMI.
